Sinovac Biotech Ltd. (NASDAQ:SVA) (" SINOVAC " or the " Company "), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the " Board ") has appointed Sven H. Borho, CFA, as director to the Board to fill in a vacancy created by a recent resignation. As a qualified audit committee financial expert under Nasdaq Rule 5605, Mr. Borho has also been elected as the Chair of the Audit Committee of the Board.